Pure Global

Procalcitonin (PCT) Quantitative Testing Drug - Vietnam Registration 240002611/PCBB-HN

Access comprehensive regulatory information for Procalcitonin (PCT) Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loแบกi B medical device is registered under number 240002611/PCBB-HN and manufactured by Boditech Med Inc.. The authorized representative in Vietnam is Cร”NG TY TNHH Vแบ N NIรŠN.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240002611/PCBB-HN
Registration Details
Vietnam MOH Registration: 240002611/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Procalcitonin (PCT) Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng Procalcitonin (PCT)
Risk Class TBYT Loแบกi B

Registration Details

240002611/PCBB-HN

000.00.19.H26-241002-0013

AFIAS PCT

SMFP-7

Company Information

Boditech Med Inc.

Technical Details

AFIAS PCT is a fluorescent immunoassay (FIA) for the quantitative determination of PCT (procalcitonin) in whole blood/plasma/serum. It is very useful in supporting the diagnosis, management, and monitoring of infections and sepsis. It is intended for in vitro diagnostic use only.

Dates and Status

Oct 03, 2024